315 related articles for article (PubMed ID: 18070553)
1. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
[TBL] [Abstract][Full Text] [Related]
2. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria.
Rengarajan J; Sassetti CM; Naroditskaya V; Sloutsky A; Bloom BR; Rubin EJ
Mol Microbiol; 2004 Jul; 53(1):275-82. PubMed ID: 15225321
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid.
Fivian-Hughes AS; Houghton J; Davis EO
Microbiology (Reading); 2012 Feb; 158(Pt 2):308-318. PubMed ID: 22034487
[TBL] [Abstract][Full Text] [Related]
5. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
[TBL] [Abstract][Full Text] [Related]
6. [Studies on pncA gene mutations in M. tuberculosis isolates].
Wu X; Zhang J; Zhong M
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jan; 23(1):40-2. PubMed ID: 11778181
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis.
Abbadi SH; Sameaa GA; Morlock G; Cooksey RC
Int J Infect Dis; 2009 Nov; 13(6):673-8. PubMed ID: 19138546
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis.
Pandey B; Grover S; Kaur J; Grover A
Sci Rep; 2019 Sep; 9(1):13617. PubMed ID: 31541138
[TBL] [Abstract][Full Text] [Related]
10. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East.
Ahmad S; Mokaddas E
Int J Antimicrob Agents; 2004 May; 23(5):473-9. PubMed ID: 15120726
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
[TBL] [Abstract][Full Text] [Related]
12. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
13. [The studies on the molecular mechanism of rifampin-resistant Mycobacterium tuberculosis].
Zhuang Y; He X; Zhang X
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):711-4. PubMed ID: 11778472
[TBL] [Abstract][Full Text] [Related]
14. [Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates].
Wu X; Zhang J; Hu Z
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):727-9. PubMed ID: 11480074
[TBL] [Abstract][Full Text] [Related]
15. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
[TBL] [Abstract][Full Text] [Related]
16. Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India.
Jadaun GP; Das R; Upadhyay P; Chauhan DS; Sharma VD; Katoch VM
Int J Antimicrob Agents; 2009 May; 33(5):483-6. PubMed ID: 19112008
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application and evaluation of the detection of five drugs resistance genes in Mycobacterium tuberculosis].
Wang W; Li H; Wu X; Wang A; Wang Z; Liu J; Chen H; Lin M; Wang J; Ye Y; Li S
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Nov; 25(11):670-3. PubMed ID: 12490122
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the role of Mycobacterium tuberculosis kasA gene mutations in isoniazid resistance.
Sun YJ; Lee AS; Wong SY; Paton NI
Clin Microbiol Infect; 2007 Aug; 13(8):833-5. PubMed ID: 17501974
[TBL] [Abstract][Full Text] [Related]
19. [Detection of KatG 315 gene mutation associated with isoniazid resistance in Mycobacterium tuberculosis by template-directed dye-terminator incorporation with fluorescence polarization detection technology].
Wang Y; Zhang WH; Zhao JR; Luo M; Zhang ZX; Bai YJ; Yan XJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):179-82. PubMed ID: 15130329
[TBL] [Abstract][Full Text] [Related]
20. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
Ahmad S; Jaber AA; Mokaddas E
Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
